Profile
Carola Jüstel is currently the Chief Executive Officer & Director at Xpress Biologics SA since 2021.
Prior to this, she was the Chief Executive Officer at Pepscan Holding NV.
From 2017 to 2019, she served as the Chief Executive Officer at Pepscan Therapeutics BV.
Carola Jüstel active positions
Companies | Position | Start |
---|---|---|
Xpress Biologics SA
Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Chief Executive Officer | 2021-08-31 |
Former positions of Carola Jüstel
Companies | Position | End |
---|---|---|
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Chief Executive Officer | 2018-12-31 |
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Xpress Biologics SA
Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Health Technology |
- Stock Market
- Insiders
- Carola Jüstel